Exagen, Inc. (XGN)
7.91
-0.22
(-2.71%)
USD |
NASDAQ |
Oct 01, 16:00
8.04
+0.13
(+1.64%)
After-Hours: 19:57
Exagen Cash from Operations (Annual) : -13.62M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.62M |
| December 31, 2024 | -13.28M |
| December 31, 2023 | -14.46M |
| December 31, 2022 | -32.14M |
| December 31, 2021 | -20.27M |
| December 31, 2020 | -14.08M |
| December 31, 2019 | -9.711M |
| Date | Value |
|---|---|
| December 31, 2018 | -9.301M |
| December 31, 2017 | -10.97M |
| December 31, 2016 | |
| December 31, 2015 | -11.90M |
| December 31, 2014 | -10.77M |
| December 31, 2013 | -6.865M |
| December 31, 2012 | -7.477M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Myriad Genetics, Inc. | 1.80M |
| BioRestorative Therapies, Inc. | -10.79M |
| CareDx, Inc. | 42.03M |
| Natera, Inc. | 215.30M |
| Sera Prognostics, Inc. | -25.62M |